RT Journal Article T1 Immunisation schedule of the Pediatric Spanish Association: 2022 recommendations A1 Alvarez Garcia, Francisco Jose A1 Cilleruelo Ortega, Maria Jose A1 Alvarez Aldean, Javier A1 Garces-Sanchez, Maria A1 Garrote Llanos, Elisa A1 Iofrio de Arce, Antonio A1 Montesdeoca Melian, Abian A1 Navarro Gomez, Maria Luisa A1 Pineda Solas, Valentin A1 Rivero Calle, Irene A1 Ruiz-Contreras, Jesus A1 Serrano Marchuet, Pepe A1 Asociacion Espanola Pediat CAV-AEP, K1 Vaccines K1 Inmunisation schedule K1 Vaccine preventable diseases K1 Infant K1 Child K1 Adolescent K1 Pneumococcal conjugate vaccine K1 Invasive meningococcal disease K1 Rubella-varicella vaccine K1 Impact K1 Immunogenicity K1 Children K1 Infants K1 Safety K1 Adults K1 Time AB After reviewing the best available scientific information, CAV-AEP publishes their new recommendations to protect pregnant women, children and adolescents living in Spain through vaccination.The same recommendations as the previous year regarding hexavalent vaccines, pneumococcal conjugate vaccine of 13 serotypes, booster with tetanus, diphtheria, pertussis and inactivated poliomyelitis (Tdpa-IPV) at 6 years and with tetanus, diphtheria and pertussis (Tdpa) at 12-14 years and pregnant women from week 27 (from week 20 if there is a high risk of preterm delivery).Also with rotavirus, tetraantigenic meningococcal B (2 + 1), meningococcal quadrivalent (MenACWY), MMR, varicella and human papillomavirus (HPV) vaccines, for both genders.As novelties this year the CAV-AEP recommends:.Influenza vaccination from 6 to 59 months of age whenever feasible and does not harm the vaccination program aimed at people at higher risk.According to official national recommendations, the CAV-AEP recommends the systematic use of COVID mRNA vaccines since 5 years old. (C) 2021 Asociacion Espanola de Pediatria. Published by Elsevier Espana, S.L.U. PB Ediciones doyma s a SN 1695-4033 YR 2022 FD 2022-01-04 LK http://hdl.handle.net/10668/21957 UL http://hdl.handle.net/10668/21957 LA es DS RISalud RD Apr 6, 2025